Container Closure Integrity Test 

Innovative solutions for the pharmaceutical industry

Pfeiffer Vacuum provides a broad range of integrity test solutions with and without the use of a specific tracer gas. No matter if you are searching for a highly sensitive test method for your laboratory or reliable and fast testing for your production process, our solutions are applicable to different types of packaging such as vials, syringes, plastic bottles or pouches.

  • High sensitivity – detection of 1 μm holes and below
  • Large detection ranges – no need for separate gross and fine leak test
  • Easy to use – automatic calibration based on traceable calibrated leaks and go / no-go result
  • Deterministic and non-destructive testing with trend analysis, 21 CFR part 11 compliant
  • USP <1207> compliant solutions, ASTM recognized, compatible with different kinds of packaging
  • Process support for GMP qualification of your test process

Pack Expo, Las Vegas
September 23 – 25, 2019
Please visit us:

North Hall, Booth N-301

Are you looking for a perfect vacuum solution? Please contact us: Pfeiffer Vacuum GmbH · Germany · T +49 6441 802-0 · www.pfeiffer-vacuum.com

Learn more

Go to article: Home | Covid-19 and the anti-vax movementGo to article: In this issueGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Mettler Toledo Company InsightGo to article: Mettler ToledoGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: PuroliteGo to article: VEGA AustraliaGo to article: Gerteis Company Insight Go to article: GerteisGo to article: CommentGo to article: US election: Trump and Biden's priorities in the Covid-19 responseGo to article: Covid-19 disruption to trials declines, but recruitment is slowGo to article: Covid-19 vaccine developments across the globeGo to article: Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 dataGo to article: AstraZeneca’s quick Covid-19 vaccine trial restart splits opinionGo to article: Q&A: Atomwise’s journey from discoverer to developerGo to article: Pfeiffer VacuumGo to article: Koehler eClinicalGo to article: Phoenix Company Insight Go to article: PhoenixGo to article: In DepthGo to article: How to combat vaccine hesitancy in the age of Covid-19Go to article: How Covid-19 has put clinical research’s diversity problem in the spotlight Go to article: No need for animal testing: improving vaccine research with GenoskinGo to article: Gout: drug development for an age-old diseaseGo to article: Treating chronic primary pain in the UKGo to article: Breast cancer breakthrough: could a new therapy silence stubborn TNBC?Go to article: Is quantum computing pharma's next big disruptor?Go to article: MimotopesGo to article: OptelGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: IWA Consulting Company Insight Go to article: IWA consultingGo to article: Nipro pharmapackagingGo to article: SwiftpakGo to article: EventsGo to article: Next issue